Search

everythinglearnresearchcommunity

for

Search:↓

The new skin cream with FOL-005 safely promotes hair growth and is stable and user-friendly.

Polymeric nanohydrogels show potential for skin drug delivery but have concerns like toxicity and regulatory hurdles.

New liposome treatment successfully delivers CRISPR to deactivate a key enzyme in androgen-related disorders.

Topical immunotherapy with DPCP is most effective for certain alopecia areata types, with success linked to age and disease duration, and influenced by a gene polymorphism.

The finasteride nanogel could be an effective topical treatment for hair loss.

Some breast cancer patients developed permanent hair loss after chemotherapy and hormonal therapy, showing patterns similar to common baldness and alopecia areata.

Current treatments for alopecia show no significant long-term benefits.

Topical retinoids effectively improve photodamaged skin.

Early diagnosis and treatment are crucial for preventing permanent hair loss in various scalp conditions, and while new treatments are promising, more research is needed to evaluate their effectiveness.

IGF-1 may affect hair growth and loss, but more research is needed to confirm effective and safe treatments.

JAK inhibitors may soon be a safe and effective treatment for alopecia areata.

Some skin medications are safe for pregnant women, but others pose risks or should not be used.

The girl with autoimmune hair loss might regrow hair within a year, and treatments can help but not prevent recurrence; dermatologist referral and corticosteroids are recommended.

Gray hair can potentially be reversed, leading to new treatments.

Chemotherapy and radiotherapy can cause skin side effects like rashes, hair loss, and nail changes, which are usually managed with conservative treatments.

Topical ruxolitinib may help some skin conditions but needs more research for alopecia areata.

Chemotherapy can cause skin side effects that affect patients' lives, but they can be managed to avoid interrupting cancer treatment.

Drug repositioning offers hope for new, affordable treatments for a genetic skin disorder called ARCI.

Metformin, usually used for diabetes, can also help treat hair loss from alopecia areata due to its ability to reduce inflammation and stimulate new hair growth.

Nanotechnology can improve alopecia treatments but faces stability challenges.

Folliculotropic mycosis fungoides has a worse prognosis than other types, with survival rates varying significantly based on subtype and organ involvement.

Hair restoration can be achieved through non-surgical treatments like minoxidil, antiandrogens, phototherapy, and PRP procedures, or through surgical methods like hair transplantation. Continued treatment is needed to maintain results, and full results are visible after 12-18 months.

Lupus can cause different skin problems, and treatments like quitting smoking and using certain creams or medicines can help.

Topical finasteride with EGCG or TA improves drug release and dermal uptake, potentially treating hair loss effectively.

Nanocarriers like liposomes and cyclodextrins improve how angiotensin-(1-7) is delivered in the body.

Nanocarrier-loaded gels improve drug delivery for cancer, skin conditions, and hair loss.

Nanoparticles improve drug delivery through the skin but more research is needed on their long-term effects and skin penetration challenges.

Nanoparticles can improve skin treatments by better targeting hair follicles, but more research is needed for advancement.

Liposomal curcumin improves skin cancer treatment effectiveness while sparing normal cells.